The results suggested that SEH1L was significantly up-regulated in most human cancers, including breast invasive cancer (BRCA), cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD) and so on. Here, SEH1L is linked to cholangiocarcinoma.